[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Andrew D. Zelenetz, MD, PhD

Specialities: Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia

Spoken languages: English

Clinical Expertise

  • Hodgkin and non-Hodgkin Lymphomas
  • Diffuse Large B Cell Lymphoma
  • Chronic Lymphocytic Leukemia

About

I am a medical oncologist with special expertise in lymphoma, and former Chief of Memorial Sloan Kettering’s Lymphoma Service. I am a member of a close-knit team that provides compassionate, multidisciplinary care to patients with lymphoma.

I have helped develop a number of the agents now approved to treat lymphoma — including 131I-tosituomab/tositumomab, bortezomib, and pralatrexate — and through clinical studies I am evaluating the benefits of novel combinations of agents. In another area of research I am working to improve the prognostic value of patients’ pathology specimens using computer-aided image analysis. I have published more than 100 papers on lymphoma research in journals such as Blood, Journal of Clinical Oncology, and Clinical Cancer Research.

I am involved in several national organizations that provide information about lymphoma treatment and fund laboratory and clinical research. I am chairperson of the Non-Hodgkin Lymphoma Guidelines panel of the National Comprehensive Cancer Network and vice chairperson of the Lymphoma Core Committee of the Cancer and Leukemia Group B. I am also a member of the scientific advisory board of the Lymphoma Research Foundation.

Location

Memorial Sloan Kettering Cancer Center: 1275 York Ave, New York, NY 10065, USA

newsletter icon

Get the latest thought leadership on your Waldenström's Macroglobulinemia delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.